Friday, 19 September 2025
Dr Sabrina Li, of the School of Geography, has been awarded a . The flagship fellowships support outstanding early career researchers and allow them to tackle complex challenges and develop as innovation leaders of the future.
Dr Li is a quantitative medical geographer, whose research is addressing how infectious diseases and pandemics such as Covid-19 disproportionately affect disadvantaged populations with limited socioeconomic resources and access to healthcare.
Her vision as a Future Leaders Fellow is to strengthen global health security by factoring in socio-environmental and individual vulnerabilities in the development of an equitable, intelligent mapping platform (EI2) to accelerate the real-time detection of emerging infectious disease risk in the UK and beyond.
I am super-excited and grateful for this opportunity. This fellowship will help embed equity into health surveillance and improve our understand of how individual and socio-environmental vulnerabilities shape infectious disease risk. It will help to promote fairer health outcomes, starting with the UK.鈥�
She added: “A huge thank you to my colleagues, mentors, and partners for their generous support along the way. I also look forward to building new partnerships and collaborations as this fellowship begins.”
Her fellowship, starting in January 2026, is worth £1.5m over four years and this long-term support will enable Dr Li to recruit a research team, including doctoral and post-doctoral researchers.
Dr Li’s Future Leaders Fellowship recognises the potential impact of her work extends beyond the UK and mapping of infectious diseases in humans, to refining disease monitoring and enabling earlier detection. This work will reduce strain on healthcare systems and promote equitable health outcomes.
She explained: “Despite the ongoing threat of infectious diseases to global health security, the world remains unprepared. Epidemics and the Covid-19 pandemic amplify existing health disparities in society, by disproportionately affecting disadvantaged populations with limited socioeconomic resources and access to healthcare.
“Integrating health equity determinants enhances risk distribution understanding, improving resource allocation and epidemic preparedness. My EI2 platform uniquely accounts for this, unlike existing mapping platforms that focus solely on pathogen-specific vulnerabilities from case counts during outbreaks in near real-time. They do not consider individual-level vulnerabilities which shape differential risk to disadvantaged and hidden populations, which are often underrepresented in surveillance.”
Dr Li's research, through intelligent and equitable mapping of emerging infectious diseases, will help better prepare health systems against the continuing threat of epidemics. This UKRI Future Leaders Fellowship is a tremendous achievement and will allow Dr Li to assemble a team with the potential to improve health security in the UK and globally."
UKRI’s latest round of Future Leaders Fellowships is supporting 77 outstanding early career researchers. The £120m funding up to seven years fellowship support and provides specialised leadership training, one-to-one coaching, mentorship and opportunities for additional seed-funding for collaborative projects.
UKRI Chief Executive Professor Sir Ian Chapman said: “UKRI’s Future Leaders Fellowships offer long-term support to outstanding researchers, helping them turn bold ideas into innovations that improve lives and livelihoods in the UK and beyond. These fellowships continue to drive excellence and accelerate the journey from discovery to public benefit.”
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.